Estradiol Valerate/Norethindrone Acetate

戊酸雌二醇/醋炔诺酮

Report date: 2023/06/09 17:12:32

Base Information

Drug NameEstradiol Valerate/Norethindrone Acetate
Drug Alias NameCliovelleCliovellan
ClassificationSmall molecules
Mechanisms of ActionEstrogen receptors agonistsProgesterone receptor agonists
TargetsEstrogen receptorsProgesterone receptor
Therapy Area/IndicationsOestrogen deficiency symptomsOsteoporosis, Postmenopausal
Global Approved IndicationsOestrogen deficiency symptomsOsteoporosis, Postmenopausal
Approved Indications in ChinaN/A
Original Approved Country/TerritorySweden
Original Approved Date2006/02/03
Country/TerritorySweden
CombinationsYes Estradiol ValerateNorethindrone Acetate
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesDr. Kade Pharmazeutische Fabrik Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesDr. Kade Pharmazeutische Fabrik Gmbh
Inactive CompaniesN/A
Active IndicationsOestrogen deficiency symptomsOsteoporosis, Postmenopausal
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A